FMS (Fresenius Medical Care AG & Co. KGaA) Company Net Income

Official company branding of Fresenius Medical Care AG & Co. KGaA (FMS)

The aggregate financial performance of Fresenius Medical Care (FMS) reflects current dynamics where the indicator remains at 1.10. The business relies on its monopoly influence in dialysis and full vertical integration. However, labor shortages and new medications create risks for margins. Management is currently implementing a network restructuring and cutting costs in loss-making regions to optimize expenditures.

FMS - Fresenius Medical Care AG Net Income over the range 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company Fresenius Medical Care AG & Co. KGaA (FMS)

- price and consensus price forecast:
Stock Quotes Fresenius Medical|FMS - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Fresenius Medical|FMS - Total Company Value
- balance sheet equity data:
Equity per Share Fresenius Medical Care|FMS - Company Net Assets|Market Cap to Book Value Multiple freseniusmedicalcare.com|FMS - Company Total Assets
- debt and liquidity details:
Aggregate Debt to Equity Fresenius Medical Care|FMS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Fresenius Medical Care AG|FMS - Company Aggregate Debts|Debts to Book Value Fresenius Medical|FMS - Company Long-Term Debt|Short-Term Debt Volume Fresenius Medical Care|Immediate Liquidity freseniusmedicalcare.com
- earnings and market ratios statistics:
FMS - Company Net Income
Fundamental valuation:FMS Fresenius Medical
Product sample of Fresenius Medical Care AG

The vertical integration of the dialysis cycle at Fresenius Medical Care (FMS) ensures a stable cash flow. An analysis of the company's actual profit allows for the separation of fundamental income from market volatility. This metric measures the daily net cash balance after deducting all operating and tax liabilities. The trend of this indicator reflects the real efficiency of managing the clinic network and production. The growing trend confirms the high resilience of the asset.

Main competitors

Net Income HCA Healthcare|THC (Tenet Healthcare) - Net Profit|Company Net Income solventum.com SOLV|Company Net Income Encompass Health Corporation (EHC)|uhsinc.com - Company Profit|DaVita Inc - Net Income|Profit After Payment of Taxes RDNT (RadNet Management)|Option Care Health - Net Profit|Profit After Tax SGRY|Premier (PINC) - Company Net Income|National Vision Holdings, Inc. - Final Profit|PGNY (Progyny Health) - Net Profit|Company Net Income Ardent Health Corp ARDT|Company Net Income Select Medical (SEM)|Net Financial Result astranahealth.com|Net Profit MD (Pediatrix Medical Group, Inc.)|US Physical Therapy (USPH) - Company Net Income|PNTG - Company Net Income|ORGO (Organogenesis Corp) - Company Profit|NUTX: Net Profit|AUNA - Net Financial Result|Net Income SBC|Net Profit Evolus Inc|Company Net Income Community Health Systems Inc (CYH)|Net Financial Result beautyhealth.com|MediWound - Net Income|Final Profit BTMD|JYNT - Company Net Income|DocGo, Inc. (DCGO) - Net Income|PIII: Net Profit|Company Net Income Gain Therapeutics Inc. (GANX)|EUDA (EUDA Health) - Net Profit|Company Profit BMGL (Basel Medical Group Limited)|Net Profit CLGN|Net Financial Result Cuprina Holdings (Cayman) Ltd.|Net Profit CCM (Concord Medical Services Holdings Limited)|AMS - Net Income|MEDIROM - Net Profit|ALBT - Net Profit|DIH Holding (DHAI) - Company Net Income|XAGE (Carmell Therapeutics Corporation) - Company Net Income|Net Income NIVF|ATIP: Final Profit|Net Profit CMAX|Net Income kindlymd.com KDLY|Net Profit MODV (ModivCare)|Net Profit Novo Integrated Sciences Inc NVOS|SSY - Company Net Income|Final Profit BACK (IMAC Corp)